Padcev: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 April 2025

  • curprev 12:5112:51, 13 April 2025 Omid Afkhami-Ardakani talk contribs 6,010 bytes +6,010 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Enfortumab vedotin-ejfv |aOrAn=an |drugClass=Antineoplastic Agent​ |indicationType=treatment |indication=Locally advanced or metastatic urothelial cancer (mUC) in adult patients and Locally advanced or metastatic urothelial cancer (mUC) in adult patients who are ineligible for cisplatin-containing chemotherapy.​ |hasBlackBoxWarning=Yes |adverseReactions=Rash, alopecia, dry skin, pruritus, perip..."
Retrieved from "https://www.wikidoc.org/index.php/Padcev"